Effect of a pharmacist intervention in Spanish community pharmacies on blood pressure control in hypertensive patients

American Journal of Health-System Pharmacy

Volumn 69, Issue 15, 2012, Pages 1311-1318

  Fikri Benbrahim, Narjis ^a   Faus, María José ^a,b   Martínez Martínez, Fernando ^b,c   Alsina, Diego González Segura ^d   Sabater Hernández, Daniel ^c  

^a Pharmaceutical Care Research Group   (Spain)

^b Faculty of Pharmacy   (Spain)

^c UNIVERSITY OF GRANADA   (Spain)

^d Almirall SA ^*  (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; RENIN INHIBITOR;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CIGARETTE SMOKING; CLINICAL PROTOCOL; COMMUNITY; DIASTOLIC BLOOD PRESSURE; EXERCISE; FEMALE; HOME MONITORING; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MONITOR; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PATIENT CARE; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT REFERRAL; PHARMACIST; PHARMACY; PRIORITY JOURNAL; QUASI EXPERIMENTAL STUDY; SELF EXAMINATION; SELF MONITORING; SMOKING CESSATION; SPAIN; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

EID: 84865964149     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp110616     Document Type: Article

References (38)

1. Rodgers A, Vaughan P, Prentice T et al. The world health report 2002. Geneva, Switzerland: World Health Organization; 2002.
2. Lewington S, Clarke R, Qizilbash N et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002; 360:1903-13. [Erratum, Lancet. 2003; 361:1060.] (Pubitemid 35472129)
3. Kaczorowski J, Chambers LW, Dolovich L et al. Improving cardiovascular health at population level: 39 community cluster randomised trial of Cardiovascular Health Awareness Program (CHAP). BMJ. 2011; 342:d442.
4. Graciani A, Zuluaga-Zuluaga MC, Banegas JR et al. [Cardiovascular mortality attributable to high blood pressure in Spanish population over 50.] Med Clin (Barc). 2008; 131:125-9. In Spanish.
5. Gueyffier F, Boissel JP, Pocock S et al. Identification of risk factors in hypertensive patients: contribution of randomized controlled trials through an individual patient database. Circulation. 1999; 100:e88-94.
6. Collins R, MacMahon S. Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. Br Med Bull. 1994; 50:272-98. (Pubitemid 24165020)
7. Barrios V, Banegas JR, Ruilope LM et al. Evolution of blood pressure control in Spain. J Hypertens. 2007; 25:1975-7. (Pubitemid 47356641)
8. Llisterri JL, Rodríguez-Roca GC, Alonso FJ et al. [Control of blood pressure in Spanish hypertensive population attended in primary health-care. PRESCAP 2006 Study.] Med Clin (Barc). 2008; 130:681-7. In Spanish.
9. Whitworth JA. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens. 2003; 21:1983-92. (Pubitemid 38296854)
10. Bakris G, Hill M, Mancia G et al. Achieving blood pressure goals globally: five core actions for health-care professionals. A worldwide call to action. J Hum Hypertens. 2008; 22:63-70. (Pubitemid 350269260)
11. Coca A, Aranda P, Bertomeu V et al. [Strategies for effective control of arterial hypertension in Spain. Consensus document.] Rev Clin Esp. 2006; 206:510-4. In Spanish.
12. Carter BL, Elliott WJ. The role of pharmacists in the detection, management, and control of hypertension: a national call to action. Pharmacotherapy. 2000; 20:119-22. (Pubitemid 30073831)
13. Evans CD, Watson E, Eurich DT et al. Diabetes and cardiovascular disease interventions by community pharmacists: a systematic review. Ann Pharmacother. 2011; 45:615-28.
14. Morgado MP, Morgado SR, Mendes LC et al. Pharmacist interventions to enhance blood pressure control and adherence to antihypertensive therapy: review and meta-analysis. Am J Health-Syst Pharm. 2011; 68:241-53.
15. Machado M, Bajcar J, Guzzo GC et al. Sensitivity of patient outcomes to pharmacist interventions. Part II: systematic review and meta-analysis in hypertension management. Ann Pharmacother. 2007; 41:1770-81. (Pubitemid 350044338)
16. Carter BL, Rogers M, Daly J et al. The potency of team-based care interventions for hypertension: a meta-analysis. Arch Intern Med. 2009; 169:1748-55.
17. Coca A, Bertomeu V, Dalfó A et al. [Self-measurement of blood pressure. Consensus paper Spain 2007.] Rev Clin Esp. 2007; 207:197-208. In Spanish.
18. Chobanian AV, Bakris GL, Black HR et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003; 42:1206-52. (Pubitemid 37553153)
19. Glynn LG, Murphy AW, Smith SM et al. Self-monitoring and other nonpharmacological interventions to improve the management of hypertension in primary care: a systematic review. Br J Gen Pract. 2010; 60:e476-88.
20. Pickering TG, Miller NH, Ogedegbe G et al. Call to action on use and reimbursement for home blood pressure monitoring: a joint scientific statement from the American Heart Association, American Society of Hypertension, and Preventive Cardiovascular Nurses Association. Hypertension. 2008; 52:10-29.
21. Cappuccio FP, Kerry SM, Forbes L et al. Blood pressure control by home monitoring: meta-analysis of randomised trials. BMJ. 2004; 329:145.
22. Stergiou G, Mengden T, Padfield PL et al. Self monitoring of blood pressure at home. BMJ. 2004; 329:870-1. (Pubitemid 39422928)
23. McManus RJ, Mant J, Bray EP et al. Telemonitoring and self-management in the control of hypertension (TASMINH2): a randomised controlled trial. Lancet. 2010; 376:163-72.
24. Agarwal R, Bills JE, Hecht TJ et al. Role of home blood pressure monitoring in overcoming therapeutic inertia and improving hypertension control: a systematic review and meta-analysis. Hypertension. 2011; 57:29-38.
25. Parati G, Stergiou GS, Asmar R et al. European Society of Hypertension practice guidelines for home blood pressure monitoring. J Hum Hypertens. 2010; 24:779-85.
26. Zillich AJ, Sutherland JM, Kumbera PA et al. Hypertension outcomes through blood pressure monitoring and evaluation by pharmacists (HOME study). J Gen Intern Med. 2005; 20:1091-6. (Pubitemid 43110257)
27. Lai LL. Community pharmacy-based hypertension disease-management program in a Latino/Hispanic-American population. Consult Pharm. 2007; 22:411-6. (Pubitemid 351729248)
28. Banegas JR, Segura J, Sobrino J et al. Effectiveness of blood pressure control outside the medical setting. Hypertension. 2007; 49:62-8. (Pubitemid 46360342)
29. Machin D, Campbell MJ. Comparing two binomials proportions. Statistical tables for design of clinical trials. Oxford: Blackwell Science; 1987:10-34.
30. Simpson SH, Johnson JA, Biggs C et al. Practice-based research: lessons from community pharmacist participants. Pharmacotherapy. 2001; 21:731-9. (Pubitemid 32506487)
31. de la Sierra A, Gorostidi M, Marin R et al. [Evaluation and management of hypertension in Spain. A consensus guide.] Med Clin (Barc). 2008; 131:104-16. In Spanish.
32. O'Brien E, Asmar R, Beilin L et al. Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens. 2005; 23:697-701. (Pubitemid 40523262)
33. Bonso E, Dorigatti F, Saladini F et al. Validation of the Visomat Comfort form device for home blood pressure measurement according to the International Protocol. Blood Press Monit. 2010; 15:63-6.
34. Sabater-Hernández D, de la Sierra A, Bellver-Monzó O et al. [Action guide for community pharmacist in patients with hypertension and cardiovascular risk. Consensus document (condensed version).] Hipertens Riesgo Vasc. 2011; 28:169-81.
35. Green BB, Cook AJ, Ralston JD et al. Effectiveness of home blood pressure monitoring, Web communication, and pharmacist care on hypertension control: a randomized controlled trial. JAMA. 2008; 299:2857-67. (Pubitemid 351930885)
36. Mehos BM, Saseen JJ, MacLaughlin EJ. Effect of pharmacist intervention and initiation of home blood pressure monitoring in patients with uncontrolled hypertension. Pharmacotherapy. 2000; 20:1384-9.
37. Magid DJ, Ho PM, Olson KL et al. A multimodal blood pressure control intervention in 3 healthcare systems. Am J Manag Care. 2011; 17:e96-103.
38. Staessen JA, Wang JG, Thijs L. Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003. J Hypertens. 2003; 21:1055-76. (Pubitemid 36667856)